Bio-Connect

Goat anti-VMAT2 / SLC18A2

Research Use Only
EB06558
Everest Biotech
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityBovine, Canine, Human, Mouse, Porcine, Rat
TargetSLC18A2
100 ug
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Everest Biotech
  • Product Name
    Goat anti-VMAT2 / SLC18A2 Antibody
  • Delivery Days Customer
    5
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry
  • Applications Supplier
    Pep-ELISA, WB, IHC
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5 mg/ml
  • Gene ID6571
  • Target name
    SLC18A2
  • Target description
    solute carrier family 18 member A2
  • Target synonyms
    monoamine neurotransmitter transporter; PKDYS2; solute carrier family 18 (vesicular monoamine transporter), member 2; SVAT; SVMT; synaptic vesicle amine transporter, brain; synaptic vesicle monoamine transporter, brain; synaptic vesicular amine transporter; VAT2; vesicle monoamine transporter type 2; vesicle monoamine/H+ antiporter; vesicular amine transporter 2; VMAT2
  • Host
    Goat
  • Scientific Description
    RefSeq number(s): NP_003045.2. GeneIDs all Nonhuman: 214084 (mouse); 25549 (rat);. Purification: Antigen affinity purified. Names and symbols: SLC18A2; VMAT2; SVAT; SVMT; VAT2; solute carrier family 18 (vesicular monoamine), member 2; MGC120477; MGC120478; MGC26538
  • Reactivity
    Bovine, Canine, Human, Mouse, Porcine, Rat
  • Reactivity Supplier
    Human, Mouse, Rat, Dog, Pig, Cow
  • Storage Instruction
    -20°C
  • UNSPSC
    12352203

References

  • Differences in the expression of catecholamine-synthesizing enzymes between vesicular monoamine transporter 1- and 2-immunoreactive glomus cells in the rat carotid body. Kato K et al., 2020 Apr, Acta Histochem
    Read more
  • Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons. Zhang S et al., 2015 Mar, Nat Neurosci
    Read more